Haematologica (Jun 2024)
FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(<i>DEK::NUP214</i>): The Mayo Clinic experience
- Clifford M. Csizmar,
- Antoine N. Saliba,
- Patricia T. Greipp,
- Hassan Alkhateeb,
- Kebede H. Begna,
- James M. Foran,
- Naseema Gangat,
- William J. Hogan,
- C. Christopher Hook,
- Mark R. Litzow,
- Abhishek A. Mangaonkar,
- Jeanne M. Palmer,
- Animesh Pardanani,
- Mithun V. Shah,
- Ayalew Tefferi,
- Mehrdad Hefazi Torghabeh,
- Alexandra P. Wolanskyj-Spinner,
- Mrinal M. Patnaik,
- Scott H Kaufmann,
- Aref Al-Kali
Affiliations
- Clifford M. Csizmar
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Antoine N. Saliba
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Patricia T. Greipp
- Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
- Hassan Alkhateeb
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Kebede H. Begna
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- James M. Foran
- Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL
- Naseema Gangat
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- William J. Hogan
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- C. Christopher Hook
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Mark R. Litzow
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Abhishek A. Mangaonkar
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Jeanne M. Palmer
- Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ
- Animesh Pardanani
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Mithun V. Shah
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Ayalew Tefferi
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Mehrdad Hefazi Torghabeh
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Alexandra P. Wolanskyj-Spinner
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Mrinal M. Patnaik
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Scott H Kaufmann
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN
- Aref Al-Kali
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- DOI
- https://doi.org/10.3324/haematol.2024.285359
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
